Market Tracker

09/23 5:16pm ET

Bristol-Myers Squibb Co (NYSE:BMY)

56.48
Delayed Data
As of Sep 23
 +0.06 / +0.11%
Today’s Change
55.02
Today|||52-Week Range
77.12
-17.90%
Year-to-Date
Bristol-Myers Squibb Stock Is Down, but That Means You Should Buy
Sep 22 / TheStreet.com - Paid Partner Content
Bristol-Myers' 'Green Shoots' Say Don't Play the Short Side
Sep 20 / TheStreet.com - Paid Partner Content
52-Week Company Lows
Sep 22 / GuruFocus News - Paid Partner Content
Opinions split on Witty regime at GSK
Sep 20 / FT.com - Paid Partner Content
Gilead to Stop GS-5745 Development for Ulcerative Colitis
Sep 22 / Zacks.com - Paid Partner Content
3 Great Dividend Stocks in the Bargain Bin for Retirees
Sep 11 / MotleyFool.com - Paid Partner Content
Bristol-Myers Opdivo's Regulatory Application Validated in EU
Sep 21 / Zacks.com - Paid Partner Content
Bristol-Myers Squibb misses mark with cancer drug
Aug 30 / FT.com - Paid Partner Content

Today’s Trading

Previous close56.42
Today’s open56.30
Day’s range56.26 - 56.95
Volume8,569,054
Average volume (3 months)9,696,575
Market cap$94.4B
Dividend yield2.69%
Data as of 4:00pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-22.50%
Earnings growth (this year)+30.12%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+4.29%
P/E ratio33.0
Price/Sales6.97
Price/Book6.58

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+0.51+0.21%
SNYSanofi-0.22-0.57%
LLYEli Lilly and Co-0.13-0.16%
NVONovo Nordisk-0.69-1.51%
Data as of 4:02pm ET, 09/23/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.64
Annual revenue (last year)$16.6B
Annual profit (last year)$1.6B
Net profit margin9.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Giovanni Caforio
Chief Financial Officer &
Executive Vice President
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts